Legend Biotech (NASDAQ:LEGN) Upgraded to Sector Outperform at Scotiabank
Scotiabank upgraded shares of Legend Biotech (NASDAQ:LEGN – Free Report) from a sector perform rating to a sector outperform rating in a research report sent to investors on Wednesday morning, Marketbeat.com reports. The brokerage currently has $65.00 target price on the stock. Other equities analysts have also recently issued research reports about the stock. UBS […]
More Stories
Mather Group LLC. Increases Stock Holdings in Bank of America Co. (NYSE:BAC)
Mather Group LLC. boosted its stake in Bank of America Co. (NYSE:BAC) by 15.8% during the 4th quarter, HoldingsChannel.com reports....
Klingman & Associates LLC Has $6 Million Stock Holdings in Amazon.com, Inc. (NASDAQ:AMZN)
Klingman & Associates LLC decreased its position in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 7.3% during the 4th quarter, according...
Signaturefd LLC Lowers Position in Liberty Broadband Co. (NASDAQ:LBRDA)
Signaturefd LLC trimmed its position in shares of Liberty Broadband Co. (NASDAQ:LBRDA – Free Report) by 23.9% in the 4th...
Mather Group LLC. Lowers Stock Holdings in SPDR Portfolio S&P 500 Growth ETF (NYSEARCA:SPYG)
Mather Group LLC. lessened its stake in shares of SPDR Portfolio S&P 500 Growth ETF (NYSEARCA:SPYG – Free Report) by...
Nucor Co. (NYSE:NUE) Shares Purchased by Mather Group LLC.
Mather Group LLC. increased its stake in Nucor Co. (NYSE:NUE – Free Report) by 4.1% in the fourth quarter, Holdings...
719 Shares in Alphabet Inc. (NASDAQ:GOOGL) Bought by Tennessee Valley Asset Management Partners
Tennessee Valley Asset Management Partners bought a new position in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) in the...